Treatment of Epithelial Fragility Disorders

The present invention provides compounds which modulate the expression of keratin genes, particularly mutated or defective keratin genes, for treating epithelial fragility disorders such as Meesmann Epithelial Corneal Dystrophy (MECD).

Patents:
WO 2,009,156,730

Inventor(s): MCLEAN IRWIN [GB]; LIAO HAIHUI [GB]

Type of Offer: Sale



« More Genetics Patents

---